Skip to main content
MEHA
NASDAQ Life Sciences

Functional Brands Receives Nasdaq Delisting Notice for Minimum Bid Price Deficiency

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Food & Beverage Stocks · Consumer
Sentiment info
Negative
Importance info
9
Price
$0.22
Mkt Cap
$3.299M
52W Low
$0.18
52W High
$8
52W Position info
22% above low
Off High info
97% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

MEHA sits 22% above its 52-week low of $0.18.

Summary

Functional Brands Inc. received a Nasdaq deficiency letter for failing to maintain the minimum $1.00 bid price, initiating a 180-day period to regain compliance and avoid potential delisting.


Key Events · Legal and Risk Events · MEHA

  • Nasdaq Delisting Notice Received

    Functional Brands Inc. was notified by Nasdaq that its common stock failed to meet the minimum $1.00 bid price requirement for continued listing.

  • 180-Day Compliance Period

    The company has until June 29, 2026, to regain compliance by maintaining a closing bid price of at least $1.00 for 10 consecutive business days.

  • Potential Reverse Stock Split

    Functional Brands Inc. stated it may consider a reverse stock split as an option to regain compliance, though there is no assurance of success.


Analysis · MEHA · Life Sciences

Functional Brands Inc. has received a notice from Nasdaq regarding its failure to meet the minimum $1.00 bid price requirement for continued listing. The company's stock has traded below this threshold for 30 consecutive business days, putting its Nasdaq listing at significant risk. While there is a 180-day compliance period, the current stock price of $0.2198 indicates a substantial challenge to regain compliance. Potential delisting could severely impact the company's liquidity, investor confidence, and ability to raise capital, making this a critical concern for investors. The company may consider a reverse stock split as an option to regain compliance, but there is no assurance of success.

At the time of this filing, MEHA was trading at $0.22 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $3.3M. The 52-week trading range was $0.18 to $8.00. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

MEHA - Latest Insights

MEHA
Jul 02, 2026, 4:16 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.0043
Real-time Price: $0.00464 info
Change: +$0.00034 (+8%) info
Market Cap: $195.838K info
MEHA
Jun 30, 2026, 6:46 PM EDT
Filing Type: 8-K
Importance Score:
10
Price at Filing: $0.0052
Real-time Price: $0.00464 info
Change: -$0.00056 (-11%) info
Market Cap: $195.838K info
MEHA
Jun 15, 2026, 8:00 AM EDT
Filing Type: 8-K
Importance Score:
10
Price at Filing: $0.0416
Real-time Price: $0.00464 info
Change: -$0.03696 (-89%) info
Market Cap: $195.838K info
MEHA
Jun 15, 2026, 8:00 AM EDT
Source: TMX Newsfile
Importance Score:
10
Price at Filing: $0.038
Real-time Price: $0.00464 info
Change: -$0.03336 (-88%) info
Market Cap: $195.838K info
MEHA
Jun 05, 2026, 2:29 PM EDT
Source: TMX Newsfile
Importance Score:
7
Price at Filing: $0.0722
Real-time Price: $0.00464 info
Change: -$0.06756 (-94%) info
Market Cap: $195.838K info